News

Analog Century's long/short fund gained 9.4% in June as AI infrastructure bets drove record first-half returns.

Companies to collaborate on global mobility technologiesAutoliv, Inc. (NYSE:ALV) and XPENG Inc.

Before the stock nearly doubled, the company’s own earnings calls were pointing to a powerful new growth engine firing up in the one place most people had stopped looking.

Investing.com -- Bank of America reinstated coverage of Figma with a Buy rating and a $30 price target on Tuesday, arguing that fears over generative AI disrupting the design software company have been overdone and that the stock's 85% decline from its 52-week high presents an attractive entry point.

SPCX is pushing deeper into AI with SpaceXAI, orbital compute plans and Anysphere deal, but heavy investment and Starship risks remain.

FLEX is benefiting from robust AI data center demand, expanding power infrastructure opportunities, improving margins and strategic acquisitions.

The fund's past suggests deep pullbacks often rebound, but what's inside the basket makes this time a unique decision.

Healthcare has become Wall Street’s bargain bin in 2026, and value hunters are starting to pay attention. Drug pricing reform, patent cliffs and post-COVID-19 hangovers have crushed multiples across Big Pharma, but the wreckage has created opportunities in two cash-generative franchises trading at single-digit forward earnings multiples. Heading into July, Novo Nordisk and Pfizer stand ... 2 Dirt Cheap Healthcare Stocks to Buy in July

Robotics and AI infrastructure stocks have ripped higher in 2026, and the path of least resistance still points up as humanoid pilots scale and AI data center spend keeps compounding. Three names give investors differentiated exposure to the buildout: chip-test giant Teradyne, lidar perception specialist Ouster and precision-sensor maker Vishay Precision Group. Each ran hard ... 3 AI Infrastructure Stocks to Buy in July

The stock has surged 160% over the past three years. Meanwhile, two key drugs could continue driving rampant growth.

Cathie Wood's Ark Invest added nearly 21,500 Bullish shares across three ETFs, but the purchases failed to lift the stock.

The financial-technology stock was the biggest riser in the S&P 500 ahead of the open, despite broader tech weakness.

One established materials supplier anchors aerospace demand; the other races to profitability through aggressive expansion.

Samsung Electronics stock dived even after it forecast a 19-fold increase in operating profit from the same period a year earlier.

USDC now accounts for roughly 67% of adjusted stablecoin transaction volume, overtaking USDT. Base and Solana are driving a shift toward faster, lower-cost stablecoin payment ...

The deal gives Vertex access to Palsonify, an oral acromegaly treatment, and atumelnant, a late-stage drug for congenital adrenal hyperplasia

The market is offering a yield on this growing business that dwarfs government debt, forcing investors to ask if the catch is too good to be true.

The best-performing stocks typically have robust sales growth, increasing margins, and rising returns on capital, and those that can maintain this trifecta year in and year out often become the legends of the investing world.

Dividend Aristocrats, the S&P 500 companies that have raised payouts for 25 or more consecutive years, remain the bedrock of income portfolios heading into the second half of 2026. Three of them stand out for July: a beaten-down quick-service leader, a biopharma machine firing on all cylinders, and a home improvement giant priced for a ... 3 Dividend Aristocrats to Buy in July

The Dow Jones crossed 53,000 for the first time, powered by financials and rising tech exposure. Here's what fueled the rally and the ETFs poised to benefit.

Funds tracking the Nasdaq-100 must now buy SpaceX stock, but a small float limits its initial weight to around 1%

One offers explosive growth but carries customer concentration risk; the other brings scale and diversification.

Crinetics Pharmaceuticals stock was surging on Tuesday after Vertex Pharmaceuticals said it had agreed to buy the biotech for $10 billion. Vertex slid 1.2%. Vertex said in a press release late Monday that it would buy Crinetics, which specializes in discovering and developing treatments for endocrine diseases, for $85 a share in cash.

DA Davidson upgraded Palantir to Buy from Neutral.

BlackRock said on Tuesday it would launch an exchange-traded fund tracking the technology-heavy Nasdaq-100 index, as it ‌seeks to tap surging investor demand for exposure to the ‌AI-driven stock market rally. The iShares Nasdaq 100 ETF, offered by the world's largest asset ​manager, will track the flagship U.S. index and start trading under the ticker on Thursday, just months after the Nasdaq revised its criteria to accelerate the inclusion of newly listed companies such as SpaceX.

Are things finally looking up for Palantir after last month's brutal sell-off?

S&P Global's upgrade of Taiwan Semiconductor Manufacturing (NYSE:TSM) to an AA- long term issuer credit rating has put fresh attention on the stock, highlighting the company’s balance sheet strength and cash generation. See our latest analysis for Taiwan Semiconductor Manufacturing. The S&P Global upgrade comes after a strong run for Taiwan Semiconductor Manufacturing, with a 30.83% 90 day share price return and a 98.83% 1 year total shareholder return, which points to building momentum as...

CVS Health (NYSE:CVS) agreed to a multi million dollar settlement over alleged false Medicaid and government program claims tied to insulin pen dispensing between 2010 and 2020. The company also received court approval to sell its Omnicare long term care pharmacy business to GenieRx, advancing a planned exit from that segment. These developments affect CVS Health’s regulatory risk profile and the future shape of its pharmacy and health services operations. CVS Health sits at the...

Vertex Pharmaceuticals (VRTX) agreed to acquire endocrine disease drugmaker Crinetics Pharmaceutical

Palantir stock has cratered in 2026 as growth investors rotate out of SaaS stocks.